near-significantP = 0.00
The moderate level evidence suggested that there was a near-significant difference with more patients reporting tolerance in the LRD group (RR, 1.06; 95% CI, 1.02–1.11; P = 0.00).
The moderate level evidence suggested that there was a near-significant difference with more patients reporting tolerance in the LRD group (RR, 1.06; 95% CI, 1.02–1.11; P = 0.00).